Baker Brothers Advisors - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 82 filers reported holding ITEOS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,646,289
-17.3%
150,3460.0%0.01%
-25.0%
Q2 2023$1,990,581
-2.7%
150,3460.0%0.01%
+9.1%
Q1 2023$2,046,209
-30.3%
150,3460.0%0.01%
-38.9%
Q4 2022$2,936,257
+2.5%
150,3460.0%0.02%
-5.3%
Q3 2022$2,864,000
-7.5%
150,3460.0%0.02%
+5.6%
Q2 2022$3,097,000
-36.0%
150,3460.0%0.02%
-35.7%
Q1 2022$4,838,000
-30.9%
150,3460.0%0.03%
-17.6%
Q4 2021$7,000,000
+72.5%
150,3460.0%0.03%
+88.9%
Q3 2021$4,059,000
+5.3%
150,3460.0%0.02%
+5.9%
Q2 2021$3,856,000
-25.0%
150,3460.0%0.02%
-22.7%
Q1 2021$5,139,000
+1.1%
150,3460.0%0.02%
+15.8%
Q4 2020$5,085,000
+23.0%
150,346
-10.3%
0.02%
+11.8%
Q3 2020$4,134,000167,5620.02%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$29,989,69616.06%
MPM BioImpact LLC 1,745,943$19,118,0765.10%
Saturn V Capital Management LP 994,756$10,892,5784.56%
Boxer Capital, LLC 1,804,058$19,754,4351.05%
RA Capital Management 4,417,259$48,368,9860.95%
683 Capital Management, LLC 810,000$8,869,5000.69%
Ikarian Capital, LLC 346,471$3,793,8570.46%
Ikarian Capital, LLC 3,056$3,346,3200.40%
BVF INC/IL 1,259,476$13,791,2620.37%
DAFNA Capital Management LLC 98,560$1,079,2320.34%
View complete list of ITEOS THERAPEUTICS INC shareholders